Status:
COMPLETED
Exogenous Ketones and Glucose Tolerance
Lead Sponsor:
University of British Columbia
Conditions:
Ketones
Dietary Supplements
Eligibility:
All Genders
30-65 years
Phase:
PHASE1
Brief Summary
The ketone body beta-hydroxybutyrate is produced during prolonged fasting or when endogenous carbohydrate stores are depleted and can be used as an alternative fuel source. Exogenous beta-hydroxybutyr...
Eligibility Criteria
Inclusion
- Not taking any medications affecting glucose metabolism.
- Elevated fasting glucose level (5.6-6.9 mmol/L) OR body mass index \>28 kg/m2 OR elevated waist circumference (\>102 cm for males, \>88 cm for females)
Exclusion
- Diagnosed with diabetes.
- Diagnosed with heart disease.
- Competitive endurance athlete (self-identified as engaged in specific endurance training in triathlon, cycling, or distance running and competing in races or competition)
- Recent (last 3 months) or current consumption of a low-carbohydrate ketogenic diet
- Current consumption of ketone supplements
- Pregnant or planning to become pregnant during the study (if female)
Key Trial Info
Start Date :
March 26 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 15 2018
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT03461068
Start Date
March 26 2018
End Date
October 15 2018
Last Update
April 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of British Columbia, Okanagan.
Kelowna, British Columbia, Canada, V1V 1V7